CytomX Therapeutics, Inc.

CTMX · Healthcare

$3.67

Capitalización: 799.69M USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar CytomX Therapeutics, Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

GlobeNewswire Inc.1 sept 2026, 12:00

CytomX Therapeutics to Present at Upcoming September Investor Conferences

CytomX Therapeutics announced that management will participate in three major healthcare investor conferences in September 2026, including Wells Fargo, Cantor Global Healthcare, and Morgan Stanley conferences. The company will host fireside chats and one-on-one investor meetings at these events. Live webcasts will be available on CytomX's website.